162 related articles for article (PubMed ID: 24487690)
1. Effect of multiplicity, laterality, and age at onset of breast cancer on familial risk of breast cancer: a nationwide prospective cohort study.
Kharazmi E; Chen T; Narod S; Sundquist K; Hemminki K
Breast Cancer Res Treat; 2014 Feb; 144(1):185-92. PubMed ID: 24487690
[TBL] [Abstract][Full Text] [Related]
2. Survival in familial and non-familial breast cancer by age and stage at diagnosis.
Kharazmi E; Försti A; Sundquist K; Hemminki K
Eur J Cancer; 2016 Jan; 52():10-8. PubMed ID: 26630529
[TBL] [Abstract][Full Text] [Related]
3. Familial risks of breast and prostate cancers: does the definition of the at risk period matter?
Brandt A; Bermejo JL; Sundquist J; Hemminki K
Eur J Cancer; 2010 Mar; 46(4):752-7. PubMed ID: 20022238
[TBL] [Abstract][Full Text] [Related]
4. Family history of breast cancer as a second primary malignancy in relatives: a nationwide cohort study.
Zheng G; Sundquist J; Sundquist K; Ji J
BMC Cancer; 2021 Nov; 21(1):1210. PubMed ID: 34772394
[TBL] [Abstract][Full Text] [Related]
5. Excess breast cancer risk in first degree relatives of CHEK2∗1100delC positive familial breast cancer cases.
Adank MA; Verhoef S; Oldenburg RA; Schmidt MK; Hooning MJ; Martens JW; Broeks A; Rookus M; Waisfisz Q; Witte BI; Jonker MA; Meijers-Heijboer H
Eur J Cancer; 2013 May; 49(8):1993-9. PubMed ID: 23415889
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
Leu M; Reilly M; Czene K
J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population.
Jara L; Gonzalez-Hormazabal P; Cerceño K; Di Capua GA; Reyes JM; Blanco R; Bravo T; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Romero C; Pakomio J; Roizen G
Breast Cancer Res Treat; 2013 Jan; 137(2):559-69. PubMed ID: 23225170
[TBL] [Abstract][Full Text] [Related]
8. Attributable risks for familial breast cancer by proband status and morphology: a nationwide epidemiologic study from Sweden.
Hemminki K; Granström C; Czene K
Int J Cancer; 2002 Jul; 100(2):214-9. PubMed ID: 12115572
[TBL] [Abstract][Full Text] [Related]
9. Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study.
Figueiredo JC; Ennis M; Knight JA; McLaughlin JR; Hood N; O'Malley F; Andrulis IL; Goodwin PJ
Breast Cancer Res Treat; 2007 Sep; 105(1):69-80. PubMed ID: 17115108
[TBL] [Abstract][Full Text] [Related]
10. Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology.
Ji J; Hemminki K
Breast Cancer Res Treat; 2007 Oct; 105(2):229-36. PubMed ID: 17115107
[TBL] [Abstract][Full Text] [Related]
11. Contribution of BRCA1 and BRCA2 germ-line mutations to the incidence of breast cancer in young women: results from a prospective population-based study in France.
Bonadona V; Sinilnikova OM; Chopin S; Antoniou AC; Mignotte H; Mathevet P; Brémond A; Martin A; Bobin JY; Romestaing P; Raudrant D; Rudigoz RC; Léoné M; Chauvin F; Easton DF; Lenoir GM; Lasset C
Genes Chromosomes Cancer; 2005 Aug; 43(4):404-13. PubMed ID: 15887246
[TBL] [Abstract][Full Text] [Related]
12. Familial aggregation of breast cancer with early onset lung cancer.
Schwartz AG; Siegfried JM; Weiss L
Genet Epidemiol; 1999 Nov; 17(4):274-84. PubMed ID: 10520210
[TBL] [Abstract][Full Text] [Related]
13. Risk of breast cancer in families of multiple affected women and men.
Bevier M; Sundquist K; Hemminki K
Breast Cancer Res Treat; 2012 Apr; 132(2):723-8. PubMed ID: 22179927
[TBL] [Abstract][Full Text] [Related]
14. CHEK2 1100delC is prevalent in Swedish early onset familial breast cancer.
Margolin S; Eiberg H; Lindblom A; Bisgaard ML
BMC Cancer; 2007 Aug; 7():163. PubMed ID: 17705858
[TBL] [Abstract][Full Text] [Related]
15. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
Chompret A
J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
[TBL] [Abstract][Full Text] [Related]
16. Birth weight-breast cancer revisited: is the association confounded by familial factors?
Oberg S; Cnattingius S; Sandin S; Lichtenstein P; Iliadou A
Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2447-52. PubMed ID: 19690178
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2.
Domchek SM; Gaudet MM; Stopfer JE; Fleischaut MH; Powers J; Kauff N; Offit K; Nathanson KL; Robson M
Breast Cancer Res Treat; 2010 Jan; 119(2):409-14. PubMed ID: 19885732
[TBL] [Abstract][Full Text] [Related]
18. Risks for familial and contralateral breast cancer interact multiplicatively and cause a high risk.
Hemminki K; Ji J; Försti A
Cancer Res; 2007 Feb; 67(3):868-70. PubMed ID: 17283115
[TBL] [Abstract][Full Text] [Related]
19. Central European BRCA2 mutation carriers: birth cohort status correlates with onset of breast cancer.
Tea MK; Kroiss R; Muhr D; Fuerhauser-Rappaport C; Oefner P; Wagner TM; Singer CF
Maturitas; 2014 Jan; 77(1):68-72. PubMed ID: 24156927
[TBL] [Abstract][Full Text] [Related]
20. The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers: Implications for counseling.
Vencken PM; Kriege M; Hooning M; Menke-Pluymers MB; Heemskerk-Gerritsen BA; van Doorn LC; Collée MM; Jager A; van Montfort C; Burger CW; Seynaeve C
Cancer; 2013 Mar; 119(5):955-62. PubMed ID: 23165859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
